ArticleObesity surgery2026
Ten-Year Outcomes of Laparoscopic Sleeve Gastrectomy with Roux-en-Y Duodenojejunal Bypass on Weight Loss, Metabolic Syndrome, and Nutrition: A Retrospective Cohort Study.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nutritional status and its determinants in obese patients with type 2 diabetes mellitus following Roux-en-Y gastric bypass surgery.BMC surgery · 2026Article
- Recent Advances in Metabolic and Bariatric Surgery: A Narrative Review of Therapeutic Strategies for Weight Loss and Metabolic Health.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo report the 10-year outcomes of laparoscopic sleeve gastrectomy with Roux-en-Y duodenojejunal bypass (LSG-DJB) on weight loss, resolution of associated medical problems, and nutritional status.
backgroundLSG-DJB is an established metabolic procedure as an alternative to laparoscopic Roux-en-Y gastric bypass (LRYGB), especially in Asia, where the incidence of gastric cancer is relatively high, but long-term data are limited.
methodsA retrospective study conducted at a single center involving 177 patients who underwent LSG-DJB, with follow-up data available for up to 10 years. Outcomes measured included weight loss, remission rates of T2DM, hypertension, dyslipidemia, and nutritional markers.
resultsDurable weight loss was maintained over 8-10 years, with %TWL of 28.9% and %EWL of 93.1%. The remission rates at 8-10 years were 35.5% for T2DM, 39.1% for hypertension, and 48.1% for dyslipidemia. Liver enzyme and uric acid levels also showed significant, sustained improvements. The rate of conversion surgery was low (4%), with no cases of severe malnutrition. The prevalence of anemia increased to 25%, although the mean hemoglobin and iron levels remained stable.
conclusionsThis is the first report on the long-term outcomes of LSG-DJB. It shows sustained weight loss and control of associated medical problems at 8-10 years, aligning with published data on RYGB. It effectively prevents severe malnutrition but requires monitoring for anemia. These findings confirm the long-term effectiveness and nutritional safety of LSG-DJB and provide strong support for future RCTs that directly compare it to other procedures over more extended follow-up periods.
Indexed as
Identifiers
41307875What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.